MACK DAVID J. has filed 28 insider transactions across 1 company since November 2024.
Most recent transaction: a grant/award of 17000 shares of BioXcel Therapeutics, Inc. ($BTAI) on January 09, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 9, 2026 | BioXcel Therapeutics, Inc. | $BTAI | MACK DAVID J. | Director | A | Stock Option (Right to Buy) | 17000 | $0.00 | 17,000.0000 | 14,196,000 | 9999.99% | 0.12% |
| Oct. 31, 2025 | BioXcel Therapeutics, Inc. | $BTAI | MACK DAVID J. | Director | M | Common Stock | 1694 | $0.00 | 20,317.0000 | 14,196,000 | 9.10% | 0.01% |
| Oct. 31, 2025 | BioXcel Therapeutics, Inc. | $BTAI | MACK DAVID J. | Director | M | Restricted Stock Units | 1694 | $0.00 | 0.0000 | 14,196,000 | 100.00% | 0.01% |
| Sept. 30, 2025 | BioXcel Therapeutics, Inc. | $BTAI | MACK DAVID J. | Director | M | Restricted Stock Units | 1694 | $0.00 | 1,694.0000 | 7,843,000 | 50.00% | 0.02% |
| Sept. 30, 2025 | BioXcel Therapeutics, Inc. | $BTAI | MACK DAVID J. | Director | M | Common Stock | 1694 | $0.00 | 18,623.0000 | 7,843,000 | 10.01% | 0.02% |
| Aug. 31, 2025 | BioXcel Therapeutics, Inc. | $BTAI | MACK DAVID J. | Director | M | Restricted Stock Units | 1693 | $0.00 | 3,387.0000 | 7,843,000 | 33.33% | 0.02% |
| Aug. 31, 2025 | BioXcel Therapeutics, Inc. | $BTAI | MACK DAVID J. | Director | M | Common Stock | 1693 | $0.00 | 16,930.0000 | 7,843,000 | 11.11% | 0.02% |
| July 31, 2025 | BioXcel Therapeutics, Inc. | $BTAI | MACK DAVID J. | Director | M | Common Stock | 1693 | $0.00 | 15,237.0000 | 7,843,000 | 12.50% | 0.02% |
| July 31, 2025 | BioXcel Therapeutics, Inc. | $BTAI | MACK DAVID J. | Director | M | Restricted Stock Units | 1693 | $0.00 | 5,080.0000 | 7,843,000 | 25.00% | 0.02% |
| June 30, 2025 | BioXcel Therapeutics, Inc. | $BTAI | MACK DAVID J. | Director | M | Common Stock | 1693 | $0.00 | 13,544.0000 | 4,834,000 | 14.29% | 0.04% |
| June 30, 2025 | BioXcel Therapeutics, Inc. | $BTAI | MACK DAVID J. | Director | M | Restricted Stock Units | 1693 | $0.00 | 6,773.0000 | 4,834,000 | 20.00% | 0.04% |
| May 31, 2025 | BioXcel Therapeutics, Inc. | $BTAI | MACK DAVID J. | Director | M | Common Stock | 1693 | $0.00 | 11,851.0000 | 4,834,000 | 16.67% | 0.04% |
| May 31, 2025 | BioXcel Therapeutics, Inc. | $BTAI | MACK DAVID J. | Director | M | Restricted Stock Units | 1693 | $0.00 | 8,466.0000 | 4,834,000 | 16.67% | 0.04% |
| April 30, 2025 | BioXcel Therapeutics, Inc. | $BTAI | MACK DAVID J. | Director | M | Common Stock | 1693 | $0.00 | 10,158.0000 | 4,834,000 | 20.00% | 0.04% |
| April 30, 2025 | BioXcel Therapeutics, Inc. | $BTAI | MACK DAVID J. | Director | M | Restricted Stock Units | 1693 | $0.00 | 10,159.0000 | 4,834,000 | 14.28% | 0.04% |
| March 31, 2025 | BioXcel Therapeutics, Inc. | $BTAI | MACK DAVID J. | Director | M | Restricted Stock Units | 1693 | $0.00 | 11,852.0000 | 2,535,000 | 12.50% | 0.07% |
| March 31, 2025 | BioXcel Therapeutics, Inc. | $BTAI | MACK DAVID J. | Director | M | Common Stock | 1693 | $0.00 | 8,465.0000 | 2,535,000 | 25.00% | 0.07% |
| Feb. 28, 2025 | BioXcel Therapeutics, Inc. | $BTAI | MACK DAVID J. | Director | M | Restricted Stock Units | 1693 | $0.00 | 13,545.0000 | 2,535,000 | 11.11% | 0.07% |
| Feb. 28, 2025 | BioXcel Therapeutics, Inc. | $BTAI | MACK DAVID J. | Director | M | Common Stock | 1693 | $0.00 | 6,772.0000 | 2,535,000 | 33.33% | 0.07% |
| Jan. 31, 2025 | BioXcel Therapeutics, Inc. | $BTAI | MACK DAVID J. | Director | M | Common Stock | 27089 | $0.00 | 81,267.0000 | 2,535,000 | 50.00% | 1.07% |
| Jan. 31, 2025 | BioXcel Therapeutics, Inc. | $BTAI | MACK DAVID J. | Director | M | Restricted Stock Units | 27089 | $0.00 | 243,810.0000 | 2,535,000 | 10.00% | 1.07% |
| Dec. 31, 2024 | BioXcel Therapeutics, Inc. | $BTAI | MACK DAVID J. | Director | M | Common Stock | 27089 | $0.00 | 54,178.0000 | 2,649,000 | 100.00% | 1.02% |
| Dec. 31, 2024 | BioXcel Therapeutics, Inc. | $BTAI | MACK DAVID J. | Director | M | Restricted Stock Units | 27089 | $0.00 | 270,899.0000 | 2,649,000 | 11.11% | 1.02% |
| Nov. 30, 2024 | BioXcel Therapeutics, Inc. | $BTAI | MACK DAVID J. | Director | M | Restricted Stock Units | 27089 | $0.00 | 297,988.0000 | 2,649,000 | 8.33% | 1.02% |
| Nov. 30, 2024 | BioXcel Therapeutics, Inc. | $BTAI | MACK DAVID J. | Director | M | Common Stock | 27089 | $0.00 | 27,089.0000 | 2,649,000 | 9999.99% | 1.02% |
| Nov. 30, 2024 | BioXcel Therapeutics, Inc. | $BTAI | MACK DAVID J. | Director | M | Common Stock | 27089 | $0.00 | 27,089.0000 | 2,649,000 | 9999.99% | 1.02% |
| Nov. 21, 2024 | BioXcel Therapeutics, Inc. | $BTAI | MACK DAVID J. | Director | A | Restricted Stock Units | 297988 | $0.00 | 297,998.0000 | 2,649,000 | 9999.99% | 11.25% |
| Nov. 21, 2024 | BioXcel Therapeutics, Inc. | $BTAI | MACK DAVID J. | Director | A | Restricted Stock Units | 325077 | $0.00 | 325,077.0000 | 2,649,000 | 9999.99% | 12.27% |